132 related articles for article (PubMed ID: 9218452)
1. Characterization of PKIgamma, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase.
Collins SP; Uhler MD
J Biol Chem; 1997 Jul; 272(29):18169-78. PubMed ID: 9218452
[TBL] [Abstract][Full Text] [Related]
2. Glutamic acid 203 of the cAMP-dependent protein kinase catalytic subunit participates in the inhibition by two isoforms of the protein kinase inhibitor.
Baude EJ; Dignam SS; Olsen SR; Reimann EM; Uhler MD
J Biol Chem; 1994 Jan; 269(3):2316-23. PubMed ID: 7905001
[TBL] [Abstract][Full Text] [Related]
3. Isoform-specific differences in the potencies of murine protein kinase inhibitors are due to nonconserved amino-terminal residues.
Gamm DM; Uhler MD
J Biol Chem; 1995 Mar; 270(13):7227-32. PubMed ID: 7706262
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function.
Dalton GD; Dewey WL
Neuropeptides; 2006 Feb; 40(1):23-34. PubMed ID: 16442618
[TBL] [Abstract][Full Text] [Related]
5. The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression.
Van Patten SM; Howard P; Walsh DA; Maurer RA
Mol Endocrinol; 1992 Dec; 6(12):2114-22. PubMed ID: 1491692
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor.
Olsen SR; Uhler MD
Mol Endocrinol; 1991 Sep; 5(9):1246-56. PubMed ID: 1770951
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse.
Scarpetta MA; Uhler MD
J Biol Chem; 1993 May; 268(15):10927-31. PubMed ID: 7684369
[TBL] [Abstract][Full Text] [Related]
8. Deficient gene expression in protein kinase inhibitor alpha Null mutant mice.
Gangolli EA; Belyamani M; Muchinsky S; Narula A; Burton KA; McKnight GS; Uhler MD; Idzerda RL
Mol Cell Biol; 2000 May; 20(10):3442-8. PubMed ID: 10779334
[TBL] [Abstract][Full Text] [Related]
9. Cloning and sequencing of the cDNA encoding the avian kidney cAMP-dependent protein kinase inhibitor protein.
Marchetto GS; Henry HL
Gene; 1995 Jun; 158(2):303-4. PubMed ID: 7607559
[TBL] [Abstract][Full Text] [Related]
10. Reproductive function in protein kinase inhibitor-deficient mice.
Belyamani M; Gangolli EA; Idzerda RL
Mol Cell Biol; 2001 Jun; 21(12):3959-63. PubMed ID: 11359903
[TBL] [Abstract][Full Text] [Related]
11. High affinity binding of the heat-stable protein kinase inhibitor to the catalytic subunit of cAMP-dependent protein kinase is selectively abolished by mutation of Arg133.
Wen W; Taylor SS
J Biol Chem; 1994 Mar; 269(11):8423-30. PubMed ID: 8132568
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase.
Van Patten SM; Ng DC; Th'ng JP; Angelos KL; Smith AJ; Walsh DA
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5383-7. PubMed ID: 2052616
[TBL] [Abstract][Full Text] [Related]
13. Binding-dependent disorder-order transition in PKI alpha: a fluorescence anisotropy study.
Hauer JA; Taylor SS; Johnson DA
Biochemistry; 1999 May; 38(21):6774-80. PubMed ID: 10346898
[TBL] [Abstract][Full Text] [Related]
14. Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA.
Zheng L; Yu L; Tu Q; Zhang M; He H; Chen W; Gao J; Yu J; Wu Q; Zhao S
Biochem J; 2000 Jul; 349(Pt 2):403-7. PubMed ID: 10880337
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the importance of hydrophobic residues in the interactions between the cAMP-dependent protein kinase catalytic subunit and the protein kinase inhibitors.
Baude EJ; Dignam SS; Reimann EM; Uhler MD
J Biol Chem; 1994 Jul; 269(27):18128-33. PubMed ID: 8027074
[TBL] [Abstract][Full Text] [Related]
16. Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.
Glass DB; Trewhella J; Mitchell RD; Walsh DA
Protein Sci; 1995 Mar; 4(3):405-15. PubMed ID: 7795524
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of synthetic peptide inhibitor and substrate of cAMP-dependent protein kinase. A study by 2D H NMR and molecular dynamics.
Padilla A; Hauer JA; Tsigelny I; Parello J; Taylor SS
J Pept Res; 1997 Mar; 49(3):210-20. PubMed ID: 9151254
[TBL] [Abstract][Full Text] [Related]
18. The catalytic subunit of Dictyostelium cAMP-dependent protein kinase -- role of the N-terminal domain and of the C-terminal residues in catalytic activity and stability.
Etchebehere LC; Van Bemmelen MX; Anjard C; Traincard F; Assemat K; Reymond C; Véron M
Eur J Biochem; 1997 Sep; 248(3):820-6. PubMed ID: 9342234
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.
Hoy JJ; Salinas Parra N; Park J; Kuhn S; Iglesias-Bartolome R
FASEB J; 2020 Oct; 34(10):13900-13917. PubMed ID: 32830375
[TBL] [Abstract][Full Text] [Related]
20. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain.
Huang LJ; Durick K; Weiner JA; Chun J; Taylor SS
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11184-9. PubMed ID: 9326583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
